Triheptanoin: Ph II data

Top-line data from a double-blind, international Phase II trial in 36 patients with seizures associated with glucose transporter type-1 deficiency syndrome showed that oral triheptanoin given 4 times daily missed the

Read the full 315 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE